Post term

World Breastfeeding Week is held in the first week of August every year.

The theme for 2024 is Closing the gap: Breastfeeding support for all.

The campaign will celebrate breastfeeding mothers in all their diversity, throughout their breastfeeding journeys, while showcasing the ways families, societies, communities and health workers can have the back of every breastfeeding mother.

This World Breastfeeding Week, let’s appreciate breastfeeding mums and ensure they get the support they need.

Universal neonatal screening for eye anomalies is recommended. This should be accompanied by diagnostic and treatment services for infants in whom an abnormality is detected.

An estimated 1.14 million children aged 0-15 years are blind or have severe visual impairment due to eye conditions. The main causes of blindness are congenital and developmental cataracts, corneal scarring, congenital ocular anomalies, retinal dystrophies, glaucoma, and retinopathy of prematurity.

Conveying the right information, for the informed decision of mothers and families, is correct and ethical.
Considerable scientific evidence is available on breastfeeding and human milk feeding as a public health strategy given its myriad benefits for both newborns and breast feeders. However, breastfeeding is often perceived by some health care professionals as simply a lifestyle choice. They fear creating guilt in those who choose not to breastfeed by "pushing" for breastfeeding.

Since 1991, the Baby-Friendly Hospital Initiative (BFHI) has sought to motivate healthcare teams caring for newborns to provide the best support for successful breastfeeding, based on the Ten Steps.

Surveillance of congenital defects (CDs) consists of: case detection, data collection and submission, coding, classification, analysis, interpretation and dissemination of information. Developing surveillance systems allows countries to have their own data to assess the size of the problem, evaluate its impact from different perspectives and assess the effect of interventions.

Human milk (HM) is recognized for its safety, efficacy, availability and cost/effectiveness. Consequently, it is the best food for newborns, even if they are small, premature or sick.

Breastfeeding improves child survival, health and development.

HM has the potential to reduce morbidities and improve health, especially in those born extremely prematurely, as it contains bioactive substances with bactericidal, immunomodulatory, and gut maturation-inducing properties.

Applying emollient or moisturizing creams or any other product on the skin of newborns is not recommended.
At birth, human skin is covered with an acid mantle, which is key to maintaining the baby’s defenses. Although there is no scientific evidence about the harmful effects of emollients, no benefits have been demonstrated in their application.
Therefore, it is not recommended to apply emollients or other products on the skin. If in doubt, it is always advisable to ask your health care team.

Routine application of topical emollients is not recommended for the prevention of skin conditions in healthy full-term infants.
This recommendation was developed by the WHO Guidelines Development Group (GDG). The GDG agreed that there was insufficient evidence on the beneficial and harmful effects of routine application of topical emollients on healthy term newborns to prevent skin conditions such as atopic dermatitis, dry skin and others.

Before organizing a neonatal transport system, there needs to be planning and coordination at the national and regional levels to align transport goals and objectives with those of the health system as a whole.
The planning process includes:
• Alignment of the objectives aimed to improve health system outcomes and transportation priority cases (and cases excluded).
• Estimation of the demand for care for each health problem selected and per region (met and unmet needs).

The primary responsibility for monitoring the implementation of the code rests with governments. Enforcement is most effective when this responsibility is shared among the main government agencies involved throughout the various stages of product commercialization.
- National legislation on the Code should indicate which government agencies are in charge of overseeing this and how it should be done.
- Manufacturers and vendors of human milk substitutes should monitor their own marketing practices at all levels.